Forecast Of The Day: Bristol-Myers Squibb's Cardiovascular Drugs Revenue

Trefis expects Bristol-Myers Squibb's (NYSE:BMY) Cardiovascular Drugs Revenue to rise from $9.2 billion in 2020 to $11.4 billion in 2021 and to $12.6 billion in 2022...